Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: The IMAGE-HD study

Experimental Neurology

Volumn 239, Issue 1, 2013, Pages 218-228

  Gray, M A ^a,e,f   Egan, G F ^a,b,c   Ando, A ^a,b   Churchyard, A ^d   Chua, P ^a   Stout, J C ^a   Georgiou Karistianis, N ^a  

^a MONASH UNIVERSITY   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Attention; DLPFC; Executive function; FMRI; Huntington's disease; Set shifting

Indexed keywords

ACCURACY; ADULT; ANTERIOR CINGULATE; ARTICLE; ATTENTION; BOLD SIGNAL; BRAIN DYSFUNCTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUNTINGTON CHOREA; INHIBITION (PSYCHOLOGY); LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENTAL DISEASE; NERVE CELL; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE;

ADULT; COGNITION; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; EXECUTIVE FUNCTION; FEMALE; GYRUS CINGULI; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; MIDDLE AGED; NEOSTRIATUM; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 84868702294     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.10.020     Document Type: Article

References (76)

1. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990, 13:266-271.
2. Allport D.A., Styles E.A., Hsieh S. Shifting intentional set: exploring the dynamic control of tasks. Attention and Performance 1994, 107-132. MIT Press, Cambridge. C. Umilta, M. Moscovitch (Eds.).
3. Aylward E.H., Nopoulos P.C., Ross C.A., Langbehn D.R., Pierson R.K., Mills J.A., Johnson H.J., Magnotta V.A., Juhl A.R., Paulsen J.S. Longitudinal change in regional brain volumes in prodromal huntington disease. J. Neurol. Neurosurg. Psychiatry 2011, 82:405-410.
4. Bachoud-Levi A.C., Remy P., Nguyen J.P., Brugieres P., Lefaucheur J.P., Bourdet C., Baudic S., Gaura V., Maison P., Haddad B., Boisse M.F., Grandmougin T., Jeny R., Bartolomeo P., Dalla Barba G., Degos J.D., Lisovoski F., Ergis A.M., Pailhous E., Cesaro P., Hantraye P., Peschanski M. Motor and cognitive improvements in patients with huntington's disease after neural transplantation. Lancet 2000, 356:1975-1979.
5. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio.
6. Beglinger L.J., O'Rourke J.J., Wang C., Langbehn D.R., Duff K., Paulsen J.S. Earliest functional declines in Huntington disease. Psychiatry Res. 2010, 178:414-418.
7. Berent S., Giordani B., Lehtinen S., Markel D., Penney J.B., Buchtel H.A., Starosta-Rubinstein S., Hichwa R., Young A.B. Positron emission tomographic scan investigations of huntington's disease: cerebral metabolic correlates of cognitive function. Ann. Neurol. 1988, 23:541-546.
8. Bonelli R.M., Cummings J.L. Frontal-subcortical circuitry and behavior. Dialogues Clin. Neurosci. 2007, 9:141-151.
9. Clark V.P., Lai S., Deckel A.W. Altered functional MRI responses in Huntington's disease. NeuroReport 2002, 13:703-706.
10. Critchley H.D., Nagai Y., Gray M.A., Mathias C.J. Dissecting axes of autonomic control in humans: Insights from neuroimaging. Auton Neurosci. 2011, 161:34-42.
11. Deckel A.W., Weiner R., Szigeti D., Clark V., Vento J. Altered patterns of regional cerebral blood flow in patients with huntington's disease: a SPECT study during rest and cognitive or motor activation. J. Nucl. Med. 2000, 41:773-780.
12. D'Esposito M., Postle B.R., Rypma B. Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Exp. Brain Res. 2000, 133:3-11.
13. Doty R.L., Shaman P., Kimmelman C.P., Dann M.S. University of pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 1984, 94:176-178.
14. Esmaeilzadeh M., Ciarmiello A., Squitieri F. Seeking brain biomarkers for preventive therapy in Huntington disease. CNS Neurosci. Ther. 2011, 17:368-386.
15. Folstein S., Abbott M.H., Chase G.A., Jensen B.A., Folstein M.F. The association of affective disorder with Huntington's disease in a case series and in families. Psychol. Med. 1983, 13:537-542.
16. Georgiou-Karistianis N., Sritharan A., Farrow M., Cunnington R., Stout J., Bradshaw J., Churchyard A., Brawn T.L., Chua P., Chiu E., Thiruvady D., Egan G. Increased cortical recruitment in Huntington's disease using a Simon task. Neuropsychologia 2007, 45:1791-1800.
17. Goldstein L.H., Bernard S., Fenwick P.B., Burgess P.W., McNeil J. Unilateral frontal lobectomy can produce strategy application disorder. J. Neurol. Neurosurg. Psychiatry 1993, 56:274-276.
18. Grace J., Mallory P.F. Frontal systems behavior scale: professional manual 2001, Psychological Assessment Resources, Lutz.
19. Gray M.A., Critchley H.D. Interoceptive basis to craving. Neuron 2007, 54:183-186.
20. Gray M.A., Minati L., Harrison N.A., Gianaros P.J., Napadow V., Critchley H.D. Physiological recordings: basic concepts and implementation during functional magnetic resonance imaging. NeuroImage 2009, 47:1105-1115.
21. Han S.D., Bangen K.J., Bondi M.W. Functional magnetic resonance imaging of compensatory neural recruitment in aging and risk for Alzheimer's disease: review and recommendations. Dement. Geriatr. Cogn. Disord. 2009, 27:1-10.
22. Hasselbalch S.G., Oberg G., Sorensen S.A., Andersen A.R., Waldemar G., Schmidt J.F., Fenger K., Paulson O.B. Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J. Neurol. Neurosurg. Psychiatry 1992, 55:1018-1023.
23. Hayden M.R., Martin W.R., Stoessl A.J., Clark C., Hollenberg S., Adam M.J., Ammann W., Harrop R., Rogers J., Ruth T., et al. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology 1986, 36:888-894.
24. Hinton S.C., Paulsen J.S., Hoffmann R.G., Reynolds N.C., Zimbelman J.L., Rao S.M. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. J. Int. Neuropsychol. Soc. 2007, 13:539-543.
25. Jersild A.T. Mental set and shift. Arch. Psychol. 1927, 14:81.
26. Jonides J., Smith E.E., Marshuetz C., Koeppe R.A., Reuter-Lorenz P.A. Inhibition in verbal working memory revealed by brain activation. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:8410-8413.
27. Julien C.L., Thompson J.C., Wild S., Yardumian P., Snowden J.S., Turner G., Craufurd D. Psychiatric disorders in preclinical Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:939-943.
28. Kane M.J., Engle R.W. The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychon. Bull. Rev. 2002, 9:637-671.
29. Kim J.S., Reading S.A.J., Brashers-Krug T., Calhoun V.D., Ross C.A., Pearlson G.D. Functional mri study of a serial reaction time task in Huntington's disease. Psychiatry Res. 2004, 131:23-30.
30. Kuhl D.E., Phelps M.E., Markham C.H., Metter E.J., Riege W.H., Winter J. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann. Neurol. 1982, 12:425-434.
31. Kuwert T., Lange H.W., Langen K.J., Herzog H., Aulich A., Feinendegen L.E. Cortical and subcortical glucose consumption measured by pet in patients with Huntington's disease. Brain 1990, 113(Pt 5):1405-1423.
32. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin. Genet. 2004, 65:267-277.
33. Lawrence A.D., Sahakian B.J., Hodges J.R., Rosser A.E., Lange K.W., Robbins T.W. Executive and mnemonic functions in early Huntington's disease. Brain 1996, 119:1633-1645.
34. Lawrence A.D., Hodges J.R., Rosser A.E., Kershaw A., Ffrench-Constant C., Rubinsztein D.C., Robbins T.W., Sahakian B.J. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998, 121:1329-1341.
35. Lawrence A.D., Sahakian B.J., Robbins T.W. Cognitive functions and corticostriatal circuits: insights from Huntington's disease. Trends Cogn. Sci. 1998, 2:379-388.
36. Leenders K.L., Frackowiak R.S., Quinn N., Marsden C.D. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography. Mov. Disord. 1986, 1:69-77.
37. Levy R., Goldman-Rakic P.S. Segregation of working memory functions within the dorsolateral prefrontal cortex. Exp. Brain Res. 2000, 133:23-32.
38. Loose R., Kaufmann C., Tucha O., Auer D.P., Lange K.W. Neural networks of response shifting: influence of task speed and stimulus material. Brain Res. 2006, 1090:146-155.
39. Mazziotta J.C., Phelps M.E., Pahl J.J., Huang S.C., Baxter L.R., Riege W.H., Hoffman J.M., Kuhl D.E., Lanto A.B., Wapenski J.A., et al. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N. Engl. J. Med. 1987, 316:357-362.
40. Mecklinger A., Weber K., Gunter T.C., Engle R.W. Dissociable brain mechanisms for inhibitory control: effects of interference content and working memory capacity. Brain Res. Cogn. Brain Res. 2003, 18:26-38.
41. Nelson H.E., Willison J., Owen A.M. National adult reading test, 2nd edition. Int. J. Geriatr. Psychiatry 1992, 7:533.
42. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 1971, 9:97-113.
43. Owen A.M., Roberts A.C., Polkey C.E., Sahakian B.J., Robbins T.W. Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1991, 29:993-1006.
44. Owen A.M., Roberts A.C., Hodges J.R., Summers B.A., Polkey C.E., Robbins T.W. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 1993, 116(Pt 5):1159-1175.
45. Passingham R.E., Rowe J.B. Dorsal prefrontal cortex: maintenance in memory or attentional selection?. Principles of Frontal Lobe Function 2002, 221-232. Oxford University Press, Oxford. D.T. Stuss, R.T. Knight (Eds.).
46. Paulsen J.S. Cognitive impairment in huntington disease: diagnosis and treatment. Curr. Neurol. Neurosci. Rep. 2011, 11:474-483.
47. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin M.L., Reynolds N.C., Rao S.M. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. Am. J. Neuroradiol. 2004, 25:1715-1721.
48. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 2006, 59:57-63.
49. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E., Ross C.A., Nance M., Guttman M., Johnson S., MacDonald M., Beglinger L.J., Duff K., Kayson E., Biglan K., Shoulson I., Oakes D., Hayden M. Detection of Huntington's disease decades before diagnosis: the predict-HD study. J. Neurol. Neurosurg. Psychiatry 2008, 79:874-880.
50. Penfield W., Evans J. The frontal lobe in man: a clinical study of maximum removals. Brain 1935, 58:115-133.
51. Petrides M. Frontal lobes and behaviour. Curr. Opin. Neurobiol. 1994, 4:207-211.
52. Petrides M. Dissociable roles of mid-dorsolateral prefrontal and anterior inferotemporal cortex in visual working memory. J. Neurosci. 2000, 20:7496-7503.
53. Petrides M. Frontal lobes and memory. Handbook of Neuropsychology 2000, Elsevier, Amsterdam. F. Boller, J. Grafman (Eds.).
54. Postle B.R. Working memory as an emergent property of the mind and brain. Neuroscience 2006, 139:23-38.
55. Robbins T.W. Dissociating executive functions of the prefrontal cortex. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1996, 351:1463-1470. (discussion 1470-1461).
56. Rowe J.B., Toni I., Josephs O., Frackowiak R.S., Passingham R.E. The prefrontal cortex: response selection or maintenance within working memory?. Science 2000, 288:1656-1660.
57. Rowe J.B., Stephan K.E., Friston K., Frackowiak R.S., Passingham R.E. The prefrontal cortex shows context-specific changes in effective connectivity to motor or visual cortex during the selection of action or colour. Cereb. Cortex 2005, 15:85-95.
58. Saft C., Schüttke A., Beste C., Andrich J., Heindel W., Pfleiderer B. fMRI reveals altered auditory processing in manifest and premanifest huntington's disease. Neuropsychologia 2008, 46:1279-1289.
59. Shallice T., Burgess P.W. Deficits in strategy application following frontal lobe damage in man. Brain 1991, 114(Pt 2):727-741.
60. Shallice T., Burgess P.W. Supervisory control of action and thought selection. Attention, Selection Awareness and Control: a Tribute to Donald Broadbent 1993, 171-187. Oxford University Press, Oxford. A.D. Baddeley, L. Weiskrantz (Eds.).
61. Shiwach R. Psychopathology in Huntington's disease patients. Acta Psychiatr. Scand. 1994, 90:241-246.
62. Smith A. Symbol Digit Modality Test (SDMT): Manual (revised) 1982, Psychological Services, Los Angeles.
63. Smith F.W., Gemmell H.G., Sharp P.F., Besson J.A. Technetium-99m HMPAO imaging in patients with basal ganglia disease. Br. J. Radiol. 1988, 61:914-920.
64. Stout J.C., Paulsen J.S., Queller S., Solomon A.C., Whitlock K.B., Campbell J.C., Carlozzi N., Duff K., Beglinger L.J., Langbehn D.R., Johnson S.A., Biglan K.M., Aylward E.H. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 2011, 25:1-14.
65. Stroop J.R. Studies of interference in serial verbal reactions. J. Exp. Psychol. 1935, 18:643-662.
66. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., Kennard C., Hicks S.L., Fox N.C., Scahill R.I., Borowsky B., Tobin A.J., Rosas H.D., Johnson H., Reilmann R., Landwehrmeyer B., Stout J.C. Biological and clinical manifestations of Huntington's disease in the longitudinal track-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009, 8:791-801.
67. Tabrizi S.J., Scahill R.I., Durr A., Roos R.A., Leavitt B.R., Jones R., Landwehrmeyer G.B., Fox N.C., Johnson H., Hicks S.L., Kennard C., Craufurd D., Frost C., Langbehn D.R., Reilmann R., Stout J.C. Biological and clinical changes in premanifest and early stage Huntington's disease in the track-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011, 10:31-42.
68. Tabrizi S.J., Reilmann R., Roos R.A., Durr A., Leavitt B., Owen G., Jones R., Johnson H., Craufurd D., Hicks S.L., Kennard C., Landwehrmeyer B., Stout J.C., Borowsky B., Scahill R.I., Frost C., Langbehn D.R. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the track-HD study: analysis of 24 month observational data. Lancet Neurol. 2012, 11:42-53.
69. Tanahashi N., Meyer J.S., Ishikawa Y., Kandula P., Mortel K.F., Rogers R.L., Gandhi S., Walker M. Cerebral blood flow and cognitive testing correlate in Huntington's disease. Arch. Neurol. 1985, 42:1169-1175.
70. Watson D., Wu K.D. Development and validation of the schedule of compulsions, obsessions, and pathological impulses (SCOPI). Assessment 2005, 12:50-65.
71. Wolf R.C., Vasic N., Schönfeldt-Lecuona C., Landwehrmeyer G.B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fmri. Brain 2007, 130:2845-2857.
72. Wolf R.C., Sambataro F., Vasic N., Schönfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp. Neurol. 2008, 213:137-144.
73. Wolf R.C., Vasic N., Carlos S.-L., Ecker D., Landwehrmeyer G.B. Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum. Brain Mapp. 2009, 30:327-339.
74. Young A.B., Penney J.B., Starosta-Rubinstein S., Markel D.S., Berent S., Giordani B., Ehrenkaufer R., Jewett D., Hichwa R. Pet scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann. Neurol. 1986, 20:296-303.
75. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983, 67:361-370.
76. Zimbelman J.L., Paulsen J.S., Mikos A., Reynolds N.C., Hoffmann R.G., Rao S.M. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J. Int. Neuropsychol. Soc. 2007, 13:758-769.